HHS Assistant Secretary Admiral Brett Giroir says the media is incorrectly reporting how long it takes for tests to be returned.
Category: Healthcare Finance News
Trump’s proposed executive orders on drug pricing may hinder R&D and drug development
The proposals, made during a global pandemic, will likely have little political support and may stifle innovation, experts say.
CMS announces two payment initiatives for COVID-19 drug treatment and counseling
One tracks the effectiveness of COVID-19 drug therapies and the other pays for counseling to slow the spread of the virus.
HHS calls on Congress to end surprise medical billing
A new report by HHS Secretary Alex Azar is calling for congressional action to combat surprise billing and to promote price transparency.
Medicare beneficiaries aren’t confident in government COVID-19 response
Over half of beneficiaries said they have “low confidence” or “no confidence” in the government’s pandemic response.
Drug price forecast estimates 3.29% increase in hospital drug spending for 2021
The top 10 COVID-19 medications have seen a combined spend increase of $200 million, showing big increases in March and April.
A large racial divide exists in the concern over ability to pay for COVID-19 treatment
Non-white adults say they’re either “extremely concerned” or “concerned” about the potential cost of care.
Pharma, biotech companies are in testing phase for a COVID-19 vaccine
Many Pfizer/BioNtech sites are in diverse communities that have been disproportionately affected by COVID-19.
Humana invests $100M into Heal’s house call and telehealth platform
The strategic investment will help Heal expand its services into Chicago, Charlotte, Houston and other new regions.
CMS releases data showing COVID-19’s impact on Medicare population
This data confirms that the COVID-19 pandemic is disproportionately affecting vulnerable populations, particularly racial and ethnic minorities.
